Published in Cancer Immunol Immunother on May 13, 2005
Regulation of tumor immunity by tumor/dendritic cell fusions. Clin Dev Immunol (2010) 0.94
Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer (2006) 0.83
Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer. Cancer Res Treat (2011) 0.79
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines. J Biomed Biotechnol (2011) 0.77
Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med (2004) 2.94
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer (2011) 2.18
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease. N Engl J Med (2016) 2.15
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer (2012) 2.09
Prevalence and clinical relevance of Th17 cells in patients with gastric cancer. J Surg Res (2012) 1.64
Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab (2010) 1.62
PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. Endocrinology (2011) 1.54
The decline and fate of an iron-induced subarctic phytoplankton bloom. Nature (2004) 1.50
IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Eur J Immunol (2007) 1.45
Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol (2008) 1.41
Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol (2007) 1.31
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B. J Clin Microbiol (2011) 1.25
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today (2011) 1.23
A mesoscale iron enrichment in the western subarctic Pacific induces a large centric diatom bloom. Science (2003) 1.22
Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev Cell (2010) 1.21
Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer (2009) 1.21
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res (2004) 1.19
Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg (2006) 1.17
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest (2006) 1.15
Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection. J Med Microbiol (2006) 1.14
Effect of age on prognosis in patients with gastric cancer. ANZ J Surg (2006) 1.11
Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol (2010) 1.11
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol (2010) 1.10
Identification of Cystatin SN as a novel tumor marker for colorectal cancer. Int J Oncol (2009) 1.09
Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol (2008) 1.09
Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg (2006) 1.07
Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy. Gastric Cancer (2007) 1.06
Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer. J Surg Oncol (2012) 1.05
Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med (2003) 1.04
Pure laparoscopic right hepatectomy in the semi-prone position using the intrahepatic Glissonian approach and a modified hanging maneuver to minimize intraoperative bleeding. Surg Today (2011) 1.02
FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res (2011) 1.02
Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology (2006) 1.01
Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial. Gastric Cancer (2013) 1.01
Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2. PLoS One (2010) 1.00
Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol (2011) 1.00
Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colorectal cancers. Cancer Sci (2006) 0.97
Immunotherapy via dendritic cells. Adv Exp Med Biol (2005) 0.97
Recent results of therapy for scirrhous gastric cancer. Surg Today (2009) 0.96
Effect of starvation on lipid metabolism and stability of DHA content of lipids in horse mackerel (Trachurus japonicus) tissues. Lipids (2003) 0.95
Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives. Surg Today (2011) 0.95
Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer. Gastric Cancer (2011) 0.94
Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice. PLoS Genet (2012) 0.94
Zinc finger protein 521, a new player in bone formation. Ann N Y Acad Sci (2010) 0.94
Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer (1999) 0.93
CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma. Oncology (2008) 0.92
Hydroxylated gedunin derivatives from Cedrela sinensis. J Nat Prod (2006) 0.92
Two-stage operation for high-risk patients with thoracic esophageal cancer: an old operation revisited. Ann Surg Oncol (2011) 0.92
Upregulation of TIM-3 and PD-1 on CD4+ and CD8+ T Cells Associated with Dysfunction of Cell-Mediated Immunity after Colorectal Cancer Operation. Yonago Acta Med (2012) 0.91
Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages. J Exp Med (2013) 0.91
Evaluation of a pylorus-preserving gastrectomy for patients preoperatively diagnosed with early gastric cancer located in the middle third of the stomach. Surg Today (2010) 0.90
Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas. Virchows Arch (2002) 0.90
Partial weight suspension: a novel murine model for investigating adaptation to reduced musculoskeletal loading. J Appl Physiol (1985) (2010) 0.90
Micrometastasis in lymph nodes of mucosal gastric cancer. Gastric Cancer (2000) 0.89
The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer (2002) 0.89
Gastric cancer in the reconstructed gastric tube after radical esophagectomy: a single-center experience. Surg Today (2011) 0.89
Clinicopathologic characteristics and prognosis of gastric cancer in young patients. Yonago Acta Med (2012) 0.88
Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep (2002) 0.88
Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery. Surg Today (2012) 0.87
The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation. Ann Surg Oncol (2002) 0.87
Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence. Hepatogastroenterology (2007) 0.87
Prognosis of patients with gastric cancer who underwent proximal gastrectomy. Int Surg (2012) 0.86
Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis. J Surg Oncol (2011) 0.86
Different incidence of synchronous liver metastasis between proximal and distal colon cancer. Surg Today (2011) 0.86
Long-term biopersistence of tangled oxidized carbon nanotubes inside and outside macrophages in rat subcutaneous tissue. Sci Rep (2013) 0.86
Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci (2007) 0.86
Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma. Fukuoka Igaku Zasshi (2013) 0.86
Docosahexaenoic acid levels in the lipids of spotted mackerel Scomber australasicus. Lipids (2006) 0.85
Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer. Clin Cancer Res (2007) 0.85
The administration of hypotonic intraperitoneal cisplatin during operation as a treatment for the peritoneal dissemination of gastric cancer. Surgery (2002) 0.85
A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice. J Periodontal Res (2006) 0.85
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma. Intern Med (2009) 0.85
Apotirucallane and tirucallane triterpenoids from Cedrela sinensis. Chem Pharm Bull (Tokyo) (2007) 0.85
Cell labeling with a novel contrast agent of magnetic resonance imaging. Cell Transplant (2010) 0.85
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients. J Gastroenterol (2013) 0.84
Nutritional assessment of patients after pylorus-preserving gastrectomy for early gastric cancer. Indian J Surg (2010) 0.83
Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma. Gastric Cancer (2004) 0.83